BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 1313671)

  • 1. Surgical treatment of ductal carcinoma in situ of the breast. 10- to 20-year follow-up.
    Simpson T; Thirlby RC; Dail DH
    Arch Surg; 1992 Apr; 127(4):468-72. PubMed ID: 1313671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
    Solin LJ; Fourquet A; McCormick B; Haffty B; Recht A; Schultz DJ; Barrett W; Fowble BL; Kuske R; Taylor M
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):3-9. PubMed ID: 8083125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
    Finkelstein SD; Sayegh R; Thompson WR
    Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast carcinoma in situ.
    Kinne DW; Petrek JA; Osborne MP; Fracchia AA; DePalo AA; Rosen PP
    Arch Surg; 1989 Jan; 124(1):33-6. PubMed ID: 2535929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ductal carcinoma in situ of the breast.
    Moore MM
    Semin Surg Oncol; 1991; 7(5):267-70. PubMed ID: 1663649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of intraductal carcinoma of the breast.
    Patchefsky AS; Schwartz GF; Finkelstein SD; Prestipino A; Sohn SE; Singer JS; Feig SA
    Cancer; 1989 Feb; 63(4):731-41. PubMed ID: 2536585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chest wall recurrence of ductal carcinoma in situ of the breast after mastectomy.
    Fisher DE; Schnitt SJ; Christian R; Harris JR; Henderson IC
    Cancer; 1993 May; 71(10):3025-8. PubMed ID: 8387874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of screen detected ductal carcinoma in situ of the female breast.
    Carpenter R; Boulter PS; Cooke T; Gibbs NM
    Br J Surg; 1989 Jun; 76(6):564-7. PubMed ID: 2547496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
    Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
    Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ carcinoma of the breast.
    Howard PW; Locker AP; Dowle CS; Ellis IO; Elston CW; Blamey RW
    Eur J Surg Oncol; 1989 Aug; 15(4):328-32. PubMed ID: 2547662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ intraduct carcinoma of the breast: a long term follow-up study.
    Millis RR; Thynne GS
    Br J Surg; 1975 Dec; 62(12):957-62. PubMed ID: 173445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.
    Childs SK; Chen YH; Duggan MM; Golshan M; Pochebit S; Punglia RS; Wong JS; Bellon JR
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):948-52. PubMed ID: 22975615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy.
    Rosner D; Lane WW; Penetrante R
    Cancer; 1991 Mar; 67(6):1498-503. PubMed ID: 1848153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of in situ cancer.
    Recht A; Connolly JL; Schnitt SJ; Harris JR
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):691-708. PubMed ID: 2558105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast conservation therapy for intraductal carcinoma of the breast.
    Kuske RR; Bean JM; Garcia DM; Perez CA; Andriole D; Philpott G; Fineberg B
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):391-6. PubMed ID: 8390417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of two treatment modalities for ductal cancer in situ of the breast.
    Arnesson LG; Smeds S; Fagerberg G; Gröntoft O
    Br J Surg; 1989 Jul; 76(7):672-5. PubMed ID: 2548651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up.
    Perera F; Yu E; Engel J; Holliday R; Scott L; Chisela F; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1239-46. PubMed ID: 14630257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment.
    Schwartz GF; Patchefsky AS; Finklestein SD; Sohn SH; Prestipino A; Feig SA; Singer JS
    Arch Surg; 1989 Jan; 124(1):29-32. PubMed ID: 2535928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The locoregional recurrence post-mastectomy for ductal carcinoma in situ: Incidence and risk factors.
    Bannani S; Rouquette S; Bendavid-Athias C; Tas P; Levêque J
    Breast; 2015 Oct; 24(5):608-12. PubMed ID: 26277546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
    Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
    Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.